Valiant Organics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Valiant Organics reported standalone revenue from operations of Rs. 73,838.31 lakhs for FY26, up ~2.7% from Rs. 71,876.18 lakhs in FY25. The company swung from a net loss of Rs. 299.84 lakhs in FY25 to a net profit of Rs. 3,435.56 lakhs in FY26, driven by improved operating performance and reduced finance costs (down from Rs. 2,405.37 lakhs to Rs. 1,819.91 lakhs). Exceptional income of Rs. 572.08 lakhs was recognized from fire insurance claim settlement for the Sarigam Division incident. The company identified Pharma Business as a new reportable segment alongside Specialty Chemicals. Statutory auditors issued un-modified opinions on both standalone and consolidated financials.
The company returned to profitability with 5x jump in PBT to Rs. 4,305.89 lakhs, significantly improving its financial position from the FY25 loss. The insurance claim settlement provides additional non-recurring income. However, the pharma segment continues to report losses (segment result of -Rs. 471.34 lakhs for FY26).